Imperative Care’s Zoom Stroke System Will Be Evaluated for Treatment of M2 Occlusions in Investigator-Initiated RCT
April 15, 2025—Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled trial (RCT) comparing aspiration thrombectomy using the company’s Zoom stroke system plus best medical treatment versus best medical treatment alone.
